封面
市場調查報告書
商品編碼
2051105

真實世界數據 (RWD) 市場:按組件、應用、最終用戶和地區分類

Real World Data (RWD) Market, By Component, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,真實世界數據 (RWD) 市場規模將達到 27.3 億美元,到 2033 年將達到 70.8 億美元。預計從 2026 年到 2033 年,該市場將以 14.6% 的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 27.3億美元
歷史數據時期: 2020-2024 預測期: 2026-2033
2026年至2033年預測期間的複合年成長率: 14.60% 2033年市場規模預測: 780億美元

真實世界數據 (RWD) 在理解和應對各個領域的複雜挑戰方面發揮著至關重要的作用。它指的是從真實世界情境中收集的信息,包括人口統計、經濟指標、醫療記錄和環境因素。與模擬或理論數據不同,全球真實世界數據 (RWD) 能夠提供關於實際事件、行為和趨勢的洞察。這使得研究人員、政策制定者和企業能夠做出明智的決策、開發精確的模型並實施有效的策略。隨著先進技術的出現和大規模數據的日益普及,全球真實世界數據 (RWD) 的分析在揭示模式、識別關聯性以及產生可操作的見解方面變得越來越有價值,這些見解能夠推動創新並改善各個領域的成果。真實世界數據市場涵蓋了從傳統臨床試驗以外的各種來源收集和分析數據。這些來源包括電子健康記錄、保險索賠數據、病患登記數據,甚至包括來自穿戴式裝置的數據。這些數據用於指導醫療保健決策和策略制定、改善患者預後並推動醫療產業的創新。

市場動態:

預計在預測期內,新產品不斷湧入市場將推動市場成長。例如,2022年11月,領先的分散式和混合臨床試驗技術解決方案供應商Castor宣布推出一項新服務,旨在簡化上市後臨床試驗流程。憑藉更廣泛的全球覆蓋範圍、真實世界數據(RWD)的整合以及試驗流程的自動化,Castor的這項最新服務可將試驗成本降低30%,並將部署時間平均縮短至僅四周。然而,資料品質和完整性、資料隱私和合規性、資料碎片化、互通性、選擇偏差以及普遍適用性等問題預計將在預測期內阻礙全球真實世界資料(RWD)市場的成長。

本研究的主要特點:

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數對全球真實世界數據 (RWD) 市場的主要參與者進行了分析:公司亮點、產品系列、主要特點、財務業績和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 《真實世界數據市場報告》的目標受眾是該行業的各類相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過各種用於分析全球真實世界數據 (RWD) 市場的策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景

第4章:全球真實世界數據(RWD)市場:按組件分類,2021-2033年

  • 服務
  • 資料集

第5章:全球真實世界數據(RWD)市場:依應用領域分類,2021-2033年

  • 藥物研發及核准
  • 市場准入與贖回/核保決策
  • 上市後監測
  • 臨床研究
  • 其他用途

第6章:全球真實世界數據(RWD)市場:依最終用戶分類,2021-2033年

  • 製藥和醫療設備公司
  • 醫療保健參與者
  • 醫療服務提供方
  • 政府機構
  • 其他

第7章 全球真實世界數據(RWD)市場:按地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 南非
    • 中非

第8章 競爭情勢

  • IQVIA Holdings Inc.
  • Optum, Inc.(a subsidiary of UnitedHealth Group)
  • Centre Corporation
  • Flatiron Health, Inc.
  • IBM Corporation
  • Tempus Labs Inc.
  • Syneos Health Inc.
  • Evidera, Inc.
  • Palantir Technologies Inc.
  • SAS Institute Inc.

第9章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI6029

Real World Data (RWD) Market is estimated to be valued at USD 2.73 Bn in 2026 and is expected to reach USD 7.08 Bn by 2033, growing at a compound annual growth rate (CAGR) of 14.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2.73 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 14.60% 2033 Value Projection: USD 7.08 Bn

Real world data plays a crucial role in understanding and addressing complex challenges across various fields. It refers to information gathered from real-life situations, such as demographics, economic indicators, healthcare records, environmental factors, and more. Unlike simulated or theoretical data, global real world data (RWD) offers insights into actual events, behaviours and trends. It enables researchers, policymakers and businesses to make informed decisions, develop accurate models, and implement effective strategies. With the advent of advanced technologies and the growing availability of large-scale data, global real world data (RWD) analysis has become increasingly valuable in uncovering patterns, identifying correlations, and generating actionable knowledge to drive innovation and improve outcomes in diverse domains. The real-world data market refers to the collection and analysis of data from various sources outside of traditional clinical trials. These sources can include electronic health records, insurance claims data, patient registries, and even data from wearable devices. This data is then used to inform healthcare decisions and strategies, improve patient outcomes, and drive innovation in the healthcare industry.

Market Dynamics:

The increasing introduction of new products in the market is expected to drive the growth of the market over the forecast period. For instance, in November 2022, Castor, a leading provider of decentralized and hybrid clinical trial technology solutions, announced a new offering to simplify post-marketing clinical trials. By extending global reach, integrating real-world data (RWD), and automating trial processes, Castor's latest offering can reduce trial costs by 30% and deployment timelines to only 4 weeks on average. However, data quality and completeness, data privacy and regulatory compliance, data fragmentation, and interoperability and selection bias and generalizability are expected to hamper growth of the global real world data (RWD) market over the forecast period.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global real world data (RWD) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include IQVIA Holdings Inc., Optum, Inc. (a subsidiary of UnitedHealth Group), Cerner Corporation, Flatiron Health, Inc., IBM Corporation, Tempus Labs Inc., Syneos Health Inc., Evidera, Inc., Palantir Technologies Inc., SAS Institute Inc.,
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The real world data market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global real world data (RWD) market.

Market Segmentation:

  • By Component (Revenue, USD Bn, 2021 - 2033)
  • Services
  • Datasets
    • Clinical settings Data
    • Claims & Billing Data
    • Pharmacy Data
    • Registry-Based Data
    • Patient-Powered Data
  • By Application (Revenue, USD Bn, 2021 - 2033)
  • Drug development and approvals
  • Market access and reimbursement/coverage decisions
  • Post-market surveillance
  • Clinical research
  • Other applications
  • By End User (Revenue, USD Bn, 2021 - 2033)
  • Pharmaceutical and medical device Companies
  • Healthcare payers
  • Healthcare providers
  • Government agencies
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Top companies in Global Real World Data (RWD) Market
  • IQVIA Holdings Inc.
  • Optum, Inc. (a subsidiary of UnitedHealth Group)
  • Cerner Corporation
  • Flatiron Health, Inc.
  • IBM Corporation
  • Tempus Labs Inc.
  • Syneos Health Inc.
  • Evidera, Inc.
  • Palantir Technologies Inc.
  • SAS Institute Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Global Real World Data (RWD) , By Component
    • Market Global Real World Data (RWD), By Application
    • Market Global Real World Data (RWD), By End user
    • Market Global Real World Data (RWD), By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Real World Data (RWD) Market , By Component, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2021 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Datasets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
      • Clinical settings Data
      • Claims & Billing Data
      • Pharmacy Data
      • Registry-Based Data
      • Patient-Powered Data

5. Global Real World Data (RWD) Market , By Application, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2021 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Drug development and approvals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Market access and reimbursement/coverage decisions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Post-market surveillance
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Clinical research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Other applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Global Real World Data (RWD) Market , By End User, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2021 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Pharmaceutical and medical device Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Healthcare prayers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Healthcare providers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Government agencies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Global Real World Data (RWD) Market , By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2021 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country 2021 - 2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
      • North Africa
      • South Africa
      • Central Africa

8. Competitive Landscape

  • IQVIA Holdings Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Optum, Inc. (a subsidiary of UnitedHealth Group)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Centre Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Flatiron Health, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • IBM Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Tempus Labs Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Syneos Health Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Evidera, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Palantir Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SAS Institute Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us